Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05925049
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-07-17
First Post:
2023-06-21
Brief Title:
A Study Utilising Data From European Union EU National Multiple Sclerosis MS Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis RRMS
Sponsor:
Organization:
Biogen